Four in 10 psoriasis patients report high shared decision-making

Less than half of psoriasis patients report high levels of shared decision-making, according to a study published online April 1 in the Journal of the American Academy of Dermatology.

Danielle Yee, M.D., from the Keck School of Medicine at the University of Southern California in Los Angeles, and colleagues used data from the 2014 to 2017 and 2019 Medical Expenditure Panel Survey to assess the association between shared decision-making and satisfaction with care among a weighted total of 3.7 million psoriasis patients.

The researchers found that the average shared decision-making score was 3.6 out of 4, and the average satisfaction with care score was 8.6 out of 10. Roughly four in 10 participants reported having high shared decision-making (score of 3.9 or higher). When adjusting for covariates, patients who had high shared decision-making had, on average, 85 percent higher satisfaction with care.

“It is important to construct a framework for carrying out shared decision-making with psoriasis patients to enhance clinician-patient communication and improve patient outcomes,” the authors write. “Future studies are needed to identify how shared decision-making can best be implemented within dermatology and how it can impact clinical outcomes.”

One author disclosed financial ties to the pharmaceutical industry.

More information:
Danielle Yee et al, Shared Decision-Making and Satisfaction with Care in Psoriasis Patients: A Population-Based Study in the United States, Journal of the American Academy of Dermatology (2023). DOI: 10.1016/j.jaad.2023.03.039

Journal information:
Journal of the American Academy of Dermatology

Source: Read Full Article